Clinical Trial Update: Carbon-13 (13C)-Spirulina Platensis Gastric Emptying Breath Test (GEBT) [NA]

View source ↗

Summary

This completed Mayo Clinic-sponsored clinical trial evaluated a carbon-13 labeled Spirulina platensis gastric emptying breath test in individuals with dyspepsia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia

Drugs mentioned

• Carbon-13 (13C) Spirulina platensis (13C-labeled Spirulina platensis)

Snippet

Sponsor: Mayo Clinic | Conditions: Dyspepsia | NA | Status: COMPLETED | Results posted: 2013-03-18